MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$1,311,433
EPS
-$1.09
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
776,410 553,657* 432,113 -
Sales and marketing
4,278 18,291.5* 45,285 68,834
Research and development
---381,061
General and administrative
1,393,060 1,634,114* 893,305 851,195
Total operating expenses
2,173,748 2,206,062.5 1,370,703 1,301,090
Operating loss
-2,173,748 -2,206,062.5* -1,370,703 -1,301,090
Other income
351 17,806* --
Digital asset staking compensation
11,060 1,280.25* --
Changes in fair value of warrant liability
---62,112
Unrealized gain on change in fair value of digital assets
738,177 -248,790.25* --
Other income (expense)
--42,018 13,066
Warrant expense
-166,257.5* --
Realized gain on change in fair value of digital assets
121,584 ---
Changes in fair value of warrant liability
8,857 192,579.5* 267,274 -
Total other expenses
---75,178
Total other (expenses) income
862,315 -588,541* -225,256 -
Loss from operations before income taxes
-1,311,433 -2,794,603.5 -1,595,959 -1,225,912
Provision for income taxes
---0
Net loss
-1,311,433 -2,794,603.5 -1,595,959 -1,225,912
Basic EPS
-1.09 -3.438 -2.1 -
Diluted EPS
-1.09 -3.438 -2.1 -
Basic Average Shares
1,199,586 812,822 761,218 -
Diluted Average Shares
1,199,586 812,822 761,218 -
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$1,311,433 Unrealized gain on change infair value of digital...$738,177 Realized gain on change infair value of digital...$121,584 Digital asset stakingcompensation$11,060 Other income$351 Loss from operationsbefore income taxes-$1,311,433 Total other(expenses) income$862,315 Changes in fair value ofwarrant liability$8,857 Operating loss-$2,173,748 Total operatingexpenses$2,173,748 General andadministrative$1,393,060 Research and development$776,410 Sales and marketing$4,278

ENDRA Life Sciences Inc. (NDRA)

ENDRA Life Sciences Inc. (NDRA)